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New cytological techniques combined with genome-
wide expression studies and ChIP-on-chip have re-
vealed that random X-inactivation is not a simple
one-step process that occurs uniformly across the en-
tire chromosome, but a complex series of events with
clear links to both the epigenetic silencing of autoso-
mal genes and the imprinted X-inactivation that occurs
in male meiosis. It appears to be less bizarre, as the
French love to say, and as such an even better model
of epigenetic gene silencing, than previously thought.
It is almost fifty years since Mary Lyon’s seminal publi-
cation describing random X-inactivation, the process
by which dosage compensation of X–linked genes is
achieved in female mammals (Lyon, 1961). Her work
was stimulated by a publication from Ohno and
Hauschka showing that in female mice, one chromo-
some of normal diploid cells was heteropyknotic
(Ohno and Hauschka, 1960). They interpreted this as
an X chromosome but left open the question of whether
the heteropyknosis occurred to the paternal X chromo-
some only or the chromosome from either parent.
Mary Lyon went on to show that the heteropyknotic X
could be either paternal or maternal in origin, in different
cells of the same animal, and that it was functionally in-
active. The mechanism behind this process was, at that
time, completely unknown. In September of this year,
the 2nd International Conference on X-inactivation, orga-
nized by Edith Heard and Phil Avner, was held in Paris
and, to the delight of all, Mary Lyon was present and
could hear for herself the progress that has been made.
So how much closer are we now to understanding X-
inactivation in mammals? A major advance occurred in
the early 90s with the discovery of the X-inactivation
center (XIC) (Brown and Willard, 1989) and the XIST
gene, which produces a noncoding RNA that spreads
along the X chromosome and acts in cis to trigger inac-
tivation (Borsani et al., 1991; Brockdorff et al., 1991;
Brown et al., 1991). But why this noncoding RNA acts
in cis and not in trans and how it induces silencing and
heterochromatin formation still remains a mystery.
What has emerged over the last five or six years, and be-
came a coherent thread throughout the meeting, was
that X-inactivation is not as unique a process as we
once thought. Genome-wide expression studies and
ChIP-on-chip show that X-inactivation does not occur
uniformly across the entire chromosome and that it in-
volves a complex series of events with clear links both
to the epigenetic silencing that occurs at autosomal
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Other organisms use quite different dosage compen-
sation mechanisms, and these are also starting to be
understood at a molecular level. It is likely that the un-
derlying processes, which include transcriptional and
posttranscriptional silencing and hyperactivation, will
inform us about the ways in which epigenetic processes
control gene expression in a mitotically heritable way in
general, including on autosomes. Indeed, the argument
that X inactivation is a useful model for understanding
these processes is more compelling now than it ever
was. In this review, I will describe some of the work pre-
sented at the conference, which supports this general
conclusion.
The Barr Body
The story started over 50 years ago with the discovery of
the Barr body, a small heterochromatic portion of the
interphase nucleus; its presence exclusively in females
suggested that it contained an X chromosome (Barr
and Bertram, 1949; Ohno and Hauschka, 1960). Indeed,
this turned out to be correct. However, new molecular
cytological techniques have revealed that the X chromo-
some territory is considerably larger than the DAPI-
dense Barr body (Chaumeil et al., 2006; Clemson et al.,
2006). The XIST RNA domain, as determined by RNA-
FISH, is also larger than the Barr body. The X-linked
genes, both those that are inactivated and those that es-
cape X inactivation, lie within, but on the outer rim of, the
XIST RNA territory (Clemson et al., 2006). The DAPI-
dense inner domain contains the highly repetitive DNA
sequence the Cot-1 fractions, which is transcriptionally
silent. There is also evidence that during the process
of inactivation, genes shift to more internal positions
(Chaumeil et al., 2006). It turns out that a group of GC-
rich repeats at the 50 end of the Xist RNA, termed the A
repeats, while not required for formation of the silent
Cot-1 compartment, are required for translocation of
genes closer to this compartment when undergoing in-
activation. It will be interesting to discover more about
the function of this highly conserved region of the RNA
molecule. Biochemical methods are being applied to
the problem, and this should lead to a clearer picture
of how the Xist RNA transcript functions in cis. More-
over, these findings are likely to impact on our under-
standing of noncoding RNA function in general.
Patterns of Gene Expression and Cytosine
Methylation along the X
The cytological findings of an outer, gene-dense shell
sit comfortably with the increasing number of X-linked
genes found to escape inactivation, both in the mouse
and in the human, and not all of these lie in the pseu-
doautosomal region as previously thought (Carrel and
Willard, 2005). Around 15% of X-linked genes escape in-
activation, at least to some degree, and an additional
10% show variable patterns. Dr. Willard discussed
SNP ChIP profiles of the inactive X, which show in-
creased histone H3 lysine 27 trimethylation, a classic
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enriched areas appear to lie in large blocks in humans
but are more scattered along the chromosome in mice.
The degree of enrichment varies from 2- to 10-fold.
The surprise here is that the fold increase is not huge
and is not consistent from gene to gene. Even more puz-
zling, some of the genes that show enrichment escape
inactivation.
This conundrum is reminiscent of some surprising re-
sults that emerged from a recent genome-wide study of
cytosine methylation in humans (Weber et al., 2005). Us-
ing primary lung fibroblasts from either males or fe-
males, Weber and colleagues found that the overall level
of methylation on the inactive X was no higher than on
the active X. In fact, the inactive X appeared to be glob-
ally hypomethylated. It has been known for some time
that the CpG promoters on the inactive X are hyperme-
thylated, and it had been assumed that the entire chro-
mosome would show a similar change. Clearly, this is
not the case. Neil Brockdorff reported similar findings
at the meeting. His group found that intergenic methyla-
tion is indeed lower on the inactive X and that methyla-
tion at CpG promoters is higher, suggesting that a redis-
tribution of methylation from intergenic and intronic
sites to CpG islands is occurring. He suggested that
L1 elements, which are known to be twice as common
on the X as on any other chromosome, act as sinks for
heterochromatin proteins, which then spread onto the
CpG islands. While it is not clear how such a mechanism
might occur, the idea adds strength to the notion, postu-
lated some years ago by Mary Lyon, that LINE1s scat-
tered along the X chromosome act as ‘‘way stations’’
promoting the spread of XCI in the X chromosome
(Lyon, 1998). Again, if this ‘‘redistribution’’ hypothesis
turns out to be true for the X, it is possible that it is occur-
ring on a smaller scale on autosomes. Indeed the notion
of ‘‘spreading’’ of gene silencing is not new to the field of
epigenetics and has been studied extensively in the
context of position effect variegation in Drosophila
and mammals (Martin and Whitelaw, 1996; Reuter and
Spierer, 1992).
Other Methods of Dosage Compensation
It has been known for some time that the mechanism by
which dosage compensation of genes on the sex chro-
mosomes is achieved varies considerably from species
to species. In marsupials, which diverged from placental
mammals around 180 million years ago, random X inac-
tivation does not occur. They preferentially silence the
paternal X chromosome, termed imprinted X inactiva-
tion (Cooper et al., 1971; Sharman, 1971). Jenny Graves
and Jeannie Lee discussed the fact that although XIST is
well conserved among eutherian mammals, no homolog
can be found in non-eutherian mammals, such as mar-
supials and monotremes, despite extensive searches
(Duret et al., 2006). Indeed, XIST may turn out to be
more important for random X inactivation than for im-
printed X inactivation. Eutherian mammals use im-
printed X inactivation at developmental stages prior to
the emergence of the inner cell mass in the blastocyst
(Huynh and Lee, 2003; Mak et al., 2004; Okamoto
et al., 2004) and indeed retain imprinted X inactivation
in the extraembryonic tissue. The use of the word ‘‘re-
tain’’ here marks a clear shift in thinking for most of us.Prior to the studies alluded to above, which revealed pa-
ternal X inactivation in the early preimplantation embryo,
imprinted X inactivation in extraembryonic tissue was
seen as a subplot, an anomaly. Of course, for the marsu-
pial biologists and evolutionary theorists, paternal X in-
activation has always been seen as the ancestral state
(Cooper et al., 1993).
X inactivation in marsupials appears to be less stable
than that seen in the somatic tissues of eutherian mam-
mals (Kaslow and Migeon, 1987). It is tissue-specific and
incomplete. While the inactive X replicates late, Jenny
Graves emphasized that it does not form a recognizable
sex chromatin body in adult cells, and there is no evi-
dence of DNA methylation of CpG islands on the inactive
X. These characteristics are more commonly associated
with the imprinted X inactivation seen in the extraembry-
onic tissue of eutherian mammals, suggesting that im-
printed X inactivation is the older, more fundamental
process from which random X inactivation emerged.
However, a recent comparative genomics analysis sug-
gests that XIST-dependent imprinted X inactivation in
eutherians did not arise directly from this ancestral
form, but independently (Duret et al., 2006), and some
interpret the fact that the paternal X is transcriptionally
active for a short period around the 2 cell stage as sup-
port for this idea (Okamoto et al., 2005). This debate is
likely to continue for some time to come.
Dosage compensation in Drosophila is achieved not
by silencing one X chromosome in females but by over-
expressing the X-linked genes in males. Interestingly,
genome-wide expression arrays have recently revealed
that genes on the X chromosome in the male mouse are
overexpressed approximately 2-fold compared to
genes on the autosomes and that X inactivation is, in
fact, a mechanism that emerged to prevent hypertran-
scription in females (Nguyen and Disteche, 2006). A
combination of biochemical and genetic studies carried
out over many years has shown that the overexpression
of X linked genes in male Drosophila is achieved by
a multicomponent dosage compensation complex
(DCC) that binds to the X chromosome. Peter Becker
discussed recent genome-wide expression arrays and
ChIP-on-chip studies (Alekseyenko et al., 2006; Gilfillan
et al., 2006; Legube et al., 2006) revealing that dosage
compensation does not occur globally across the entire
chromosome and that the overexpression is mostly not
2-fold. Each gene is compensated to a different degree.
This is reminiscent of the variable levels of silencing re-
ported among different genes on the inactive X in mam-
mals (see above). Furthermore, the complex binds pref-
erentially to the 30 end of genes, rather than the 50 end,
suggesting that regulation is achieved at the level of
transcriptional elongation. It will be interesting to see
how common this is as a mechanism for controlling
gene expression in other contexts.
In worms, dosage compensation is achieved by re-
ducing the expression of X-linked genes on both X chro-
mosomes in females. Relatively little is known about this
process but it is clearly different from the mechanisms
that have evolved in mammals and flies. The main point
to be made here is to emphasize the plasticity of the pro-
cess of dosage compensation over evolutionary time.
This is consistent with the idea that there is nothing
particularly unique about dosage compensation at sex
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more of the mechanisms that have evolved to control
gene expression in general.
Paternal X Inactivation
As mentioned above, the most parsimonious model of
the evolution of X inactivation seen in placental mam-
mals is that it evolved from a dosage compensation
mechanism whereby the paternal X was silenced in the
gametes and remained silenced in the somatic tissue
of the offspring (Cooper et al., 1993; Huynh and Lee,
2003). So what do we know about the mechanisms of
paternal X inactivation?
In male eutherian mammals, the single X chromo-
some, along with the Y chromosome, undergoes meiotic
sex chromosome inactivation (MSCI) during spermato-
genesis (Solari, 1974). This occurs at the pachytene
stage, when most chromosomes are paired, but the un-
paired X and Y share a unique chromatin compartment
in the nucleus called the XY or sex body. Also called mei-
otic silencing of unsynapsed chromatin (MSUC), until
recently, it had been thought that MSCI in mammals is
reversed after meiosis and during spermiogenesis;
however, recent data from James Turner’s and Jeannie
Lee’s laboratories suggest that MSCI persists in sper-
matids (Namekawa et al., 2006; Turner et al., 2006). It
was therefore proposed that the silent paternal X in the
next generation is directly descended from the silent
spermatid X. Some genes escape the inactivation, and
these could turn out to be the same as those that escape
random X inactivation. We will see.
It had been thought that the establishment of im-
printed X inactivation in the extraembryonic tissue oc-
curred in a lineage-specific manner at the blastocyst
stage. However Xist RNA, the cis-acting signal that initi-
ates X inactivation, is expressed from Xp as early as the
2 cell stage (Huynh and Lee, 2003; Mak et al., 2004; Oka-
moto et al., 2004), and so it seems more likely that ran-
dom X inactivation in the inner cell mass occurs after
reactivation of the paternal X.
Counting
The very earliest description of X inactivation noted that
while one X chromosome was heteropyknotic in a female
diploid cell, two were heteropyknotic in a female tetra-
ploid cell (Ohno and Hauschka, 1960). Clearly the cells
could count. They somehow sense how many X chro-
mosomes there are for each diploid set of autosomes,
and anything above one gets silenced. The mechanism
remains unknown. The simplest model is that auto-
somes produce a factor, ‘‘blocking factor,’’ which pre-
vents silencing, and that the amount is only sufficient
to bind to one X, which therefore remains active. Dele-
tion studies suggest that the region just downstream
of Xist is the docking site. The X carrying a deletion of
this region is always silenced in both male and heterozy-
gous female cells (Clerc and Avner, 1998). However, the
region includes the Tsix and Xite regions, which are
known to play a role in choice, and this complicates in-
terpretation of the data. Even in the absence of under-
standing the details, this model requires the involvement
of trans-acting factors for which the amount matters.
An alternative model has recently been proposed.
Transient homologous chromosome pairing of the twoXs has been detected using FISH in differentiating
mouse embryonic stem (ES) cells, a model that recapit-
ulates X chromosome inactivation in culture (Bacher
et al., 2006; Xu et al., 2006). This pairing occurs at the
onset of X inactivation, and deletion of Tsix and Xite
disrupts pairing. Insertion of these elements onto auto-
somes induces X-autosome pairing. The authors pro-
pose that this process regulates counting and mutually
exclusive choice. It remains unclear how this could
involve a sensing of the X/autosome ratio.
Random X Inactivation
A new idea gaining momentum is that random X inacti-
vation is essentially a stochastic process. Recently, it
has been proposed that random X inactivation is a com-
bination of stochastic X inactivation in which both X
chromosomes have a certain probability (say, 0.5) of
being silenced and a feedback mechanism that sup-
presses the inactivation of the only active X (Mlynarc-
zyk-Evans et al., 2006). At the meeting, Barbara Panning
summarized the relevant fluorescence studies of X chro-
mosomal dynamics, and Joost Gribnau presented fol-
low-up data from tetraploid ES cells further supporting
this idea. There could be selection against cells express-
ing both X chromosomes or no X chromosomes. Admit-
tedly, such a system would involve significant cell death,
which has not been reported but could be difficult to
detect.
One of the appealing aspects of the idea that stochas-
tic events are involved in random X inactivation is that
it places the process in the broader field of monoallelic
gene silencing of autosomes of both imprinted and non-
imprinted varieties. Instances of monoallelic expression
are most often detected by their variegated expression
patterns. There are numerous examples of variegated
expression of loci in organisms from humans down to
yeast. It is interesting to note that a recent screen for
modifiers of position effect variegation in the mouse
has pulled out, among other things, a novel gene that
is homozygous lethal in females but not males; the ho-
mozygous female embryos, prior to death, show a failure
of hypermethylation normally associated with CpG pro-
moters on the inactive X (Blewitt et al., 2005). This brings
to mind an intriguing finding, published some years ago,
that in 32 genetically identical F1 hybrid (C57BL/6J/
Spretus) mice, differential expression of homologous
alleles at three X-linked genes showed considerable var-
iation in ratio from mouse to mouse (Greenwood et al.,
1997). The B6/SP ratio of Hprt expression varied from
0.9 to 0.2. In all cases, as expected, there was coordi-
nate control of the X chromosome homologs. As the
authors suggest, interindividual variation could result
from stochastic factors operating on the X inactivation
center at the time of homolog choice.
Summary
So it seems that the deeper we drill down into the mech-
anisms underlying X inactivation, the closer we get to
mechanisms of epigenetic gene silencing used through-
out the genome. The original discovery of X inactivation
in mammals, based on the visible detection of the Barr
body in interphase nuclei, suggested a uniqueness
that was perhaps misleading. Indeed, closer inspection
of such nuclei reveals many small heteropyknotic
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762speckles. Perhaps they too will point the way to
underlying mechanisms that are shared between X inac-
tivation and the epigenetics of autosomal chromatin
regulation.
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